JPRN-UMIN000010272
Completed
未知
Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgery - Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgery
Conditionselective hip surgery
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- elective hip surgery
- Sponsor
- Osaka University Graduate School of Medicine
- Enrollment
- 390
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Impact of antithrombotic therapy for the short-term and long-term prognosis after laparoscopic gastrectomygastric cacncerJPRN-UMIN000044460Ehime University119
Active, not recruiting
Phase 1
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolismIntermediate high-risk acute pulmonary embolismTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2018-000816-96-SIAP-HP/ DRCI650
Active, not recruiting
Phase 1
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolismIntermediate high-risk acute pulmonary embolismTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2018-000816-96-FRAP-HP/ DRCI300
Active, not recruiting
Phase 1
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolismIntermediate high-risk acute pulmonary embolismTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2018-000816-96-ESAP-HP/ DRCI650
Active, not recruiting
Phase 1
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolismIntermediate high-risk acute pulmonary embolismTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2018-000816-96-NLAP-HP/ DRCI650